Search

Displaying results 181 - 190 of 2873 in total
  1. Pathway

    Acrivastine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175099
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Calcium · Acrivastine
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  2. Pathway

    Ebastine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175100
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Calcium · Ebastine
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  3. Pathway

    Quetiapine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175112
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Quetiapine · Calcium
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  4. Pathway

    Isothipendyl H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175114
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Calcium · Isothipendyl
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  5. Pathway

    Deptropine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175120
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Calcium · Deptropine
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  6. Pathway

    Cetirizine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175121
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Cetirizine · Calcium
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  7. Pathway

    Loratadine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175122
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Doxylamine · Calcium
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  8. Pathway

    Fexofenadine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175123
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Fexofenadine · Calcium
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  9. Pathway

    Desloratadine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175124
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Doxylamine · Calcium
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1
  10. Pathway

    Mizolastine H1-Antihistamine Immune Response Action Pathway

    smpdb.ca/view/SMP0175130
    Drug action

    Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release.

    Drugs: Calcium · Mizolastine
    Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent L-type calcium channel subunit beta-1